United States · FDA National Drug Code directory
MELOXICAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-159_2c9a4c52-7394-432a-9e50-b51c8a90972e
- Product NDC
- 69097-159
- Form
- TABLET
- Composition / generic term
- meloxicam
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060719
- Source listing expiry
- 20261231
Source-listed ingredients
- MELOXICAM — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (69097-159-07) · 69097-159-07
- 500 TABLET in 1 BOTTLE (69097-159-12) · 69097-159-12
- 1000 TABLET in 1 BOTTLE (69097-159-15) · 69097-159-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →